Literature DB >> 455887

Lorcainide. I. Saturable presystemic elimination.

E Jähnchen, H Bechtold, W Kasper, F Kersting, H Just, J Heykants, T Meinertz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 455887     DOI： 10.1002/cpt1979262187

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  14 in total

1.  Dose dependent pharmacokinetics of midazolam.

Authors:  L D Bornemann; B H Min; T Crews; M M Rees; H P Blumenthal; W A Colburn; I H Patel
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 2.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

3.  Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil.

Authors:  M Eichelbaum; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

5.  Bioavailability and saturation of the presystemic metabolism of oral lorcainide therapy initiated in three different dose regimens.

Authors:  W K Amery; J Heykants; K Bruyneel; R Terryn
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  C e Eiriksson; R N Brogden
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

8.  Excretion and metabolism of lorcainide in rats, dogs and man.

Authors:  W Meuldermans; R Hurkmans; E Swysen; J Hendrickx; J Thijssen; W Lauwers; J Heykants
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

Review 9.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

10.  Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man.

Authors:  P N Bennett; L J Aarons; M R Bending; J A Steiner; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1982-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.